CYCCP
Price
$5.00
Change
+$0.16 (+3.31%)
Updated
Sep 9 closing price
Capitalization
N/A
LIMN
Price
$2.46
Change
+$0.15 (+6.49%)
Updated
Sep 9, 04:59 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

CYCCP vs LIMN

Header iconCYCCP vs LIMN Comparison
Open Charts CYCCP vs LIMNBanner chart's image
Cyclacel Pharmaceuticals
Price$5.00
Change+$0.16 (+3.31%)
Volume$984
CapitalizationN/A
Liminatus Pharma
Price$2.46
Change+$0.15 (+6.49%)
Volume$682
CapitalizationN/A
CYCCP vs LIMN Comparison Chart in %
Loading...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCCP vs. LIMN commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCCP is a StrongBuy and LIMN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 10, 2025
Stock price -- (CYCCP: $5.00 vs. LIMN: $2.45)
Brand notoriety: CYCCP and LIMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCCP: 14% vs. LIMN: 116%
Market capitalization -- CYCCP: $0 vs. LIMN: $0
CYCCP [@Biotechnology] is valued at $0. LIMN’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.65B to $0. The average market capitalization across the [@Biotechnology] industry is $1.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCCP’s FA Score shows that 1 FA rating(s) are green whileLIMN’s FA Score has 1 green FA rating(s).

  • CYCCP’s FA Score: 1 green, 4 red.
  • LIMN’s FA Score: 1 green, 4 red.
According to our system of comparison, CYCCP is a better buy in the long-term than LIMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCCP’s TA Score shows that 5 TA indicator(s) are bullish while LIMN’s TA Score has 4 bullish TA indicator(s).

  • CYCCP’s TA Score: 5 bullish, 5 bearish.
  • LIMN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CYCCP is a better buy in the short-term than LIMN.

Price Growth

CYCCP (@Biotechnology) experienced а -1.96% price change this week, while LIMN (@Biotechnology) price change was -18.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.91%. For the same industry, the average monthly price growth was +17.16%, and the average quarterly price growth was +35.63%.

Industries' Descriptions

@Biotechnology (+1.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYCCP YTD gains are higher at: -27.045 vs. LIMN (-78.164).
CYCCPLIMNCYCCP / LIMN
CapitalizationN/AN/A-
EBITDA-10.41MN/A-
Gain YTD-27.045-78.16435%
P/E RatioN/AN/A-
Revenue10KN/A-
Total Cash4.28MN/A-
Total Debt10KN/A-
FUNDAMENTALS RATINGS
CYCCP: Fundamental Ratings
CYCCP
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPLIMN
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 3 days ago
29%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 3 days ago
35%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 7 days ago
14%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 3 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 3 days ago
17%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 3 days ago
23%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 3 days ago
31%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 3 days ago
35%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.590.37
+1.59%
GameStop Corp
SPY650.331.50
+0.23%
SPDR® S&P 500® ETF
TSLA346.970.57
+0.16%
Tesla
BTC.X111530.550000-540.882800
-0.48%
Bitcoin cryptocurrency
AAPL234.35-3.53
-1.48%
Apple

CYCCP and

Correlation & Price change

A.I.dvisor tells us that CYCCP and VALN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCCP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCCP
1D Price
Change %
CYCCP100%
+3.31%
VALN - CYCCP
24%
Poorly correlated
+4.81%
SRPT - CYCCP
23%
Poorly correlated
+0.23%
AURA - CYCCP
21%
Poorly correlated
-0.15%
KZIA - CYCCP
21%
Poorly correlated
-0.62%
TECH - CYCCP
21%
Poorly correlated
+0.17%
More

LIMN and

Correlation & Price change

A.I.dvisor tells us that LIMN and AIM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LIMN and AIM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMN
1D Price
Change %
LIMN100%
+6.06%
AIM - LIMN
29%
Poorly correlated
-0.77%
SGMT - LIMN
27%
Poorly correlated
-1.99%
ALT - LIMN
23%
Poorly correlated
+1.89%
CYCCP - LIMN
23%
Poorly correlated
+3.31%
LYEL - LIMN
22%
Poorly correlated
+0.92%
More